These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29420365)

  • 1. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
    Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
    Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance.
    Mascitti M; Santarelli A; Sartini D; Rubini C; Colella G; Salvolini E; Ganzetti G; Offidani A; Emanuelli M
    Melanoma Res; 2019 Apr; 29(2):151-156. PubMed ID: 30431528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide N-methyltransferase in nonmelanoma skin cancers.
    Pompei V; Salvolini E; Rubini C; Lucarini G; Molinelli E; Brisigotti V; Pozzi V; Sartini D; Campanati A; Offidani A; Emanuelli M
    Eur J Clin Invest; 2019 Dec; 49(12):e13175. PubMed ID: 31571214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
    Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
    J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma.
    Sartini D; Santarelli A; Rossi V; Goteri G; Rubini C; Ciavarella D; Lo Muzio L; Emanuelli M
    Mol Med; 2007; 13(7-8):415-21. PubMed ID: 17622326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
    Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.
    Seta R; Mascitti M; Campagna R; Sartini D; Fumarola S; Santarelli A; Giuliani M; Cecati M; Muzio LL; Emanuelli M
    Clin Oral Investig; 2019 Feb; 23(2):829-838. PubMed ID: 29882109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro.
    Pozzi V; Molinelli E; Campagna R; Serritelli EN; Cecati M; De Simoni E; Sartini D; Goteri G; Martin NI; van Haren MJ; Salvolini E; Simonetti O; Offidani A; Emanuelli M
    Hum Cell; 2024 May; 37(3):729-738. PubMed ID: 38504052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
    Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
    Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines.
    Campagna R; Salvolini E; Pompei V; Pozzi V; Salvucci A; Molinelli E; Brisigotti V; Sartini D; Campanati A; Offidani A; Emanuelli M
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1039-1048. PubMed ID: 34018676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide
    Holstein S; Venz S; Junker H; Walther R; Stope MB; Zimmermann U
    Anticancer Res; 2019 Oct; 39(10):5427-5436. PubMed ID: 31570437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
    Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
    Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
    Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
    Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma.
    Emanuelli M; Santarelli A; Sartini D; Ciavarella D; Rossi V; Pozzi V; Rubini C; Lo Muzio L
    Histol Histopathol; 2010 Jan; 25(1):15-20. PubMed ID: 19924637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma.
    Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y
    J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide N-methyltransferase protein expression in renal cell cancer.
    Zhang J; Xie XY; Yang SW; Wang J; He C
    J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Clinical Significance of Nicotinamide N-Methyltransferase in Cervical Squamous Cell Carcinoma.
    Akar S; Harmankaya İ; Uğraş S; Çelik Ç
    Int J Gynecol Pathol; 2020 May; 39(3):289-295. PubMed ID: 31033801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts.
    Mascitti M; Sartini D; Togni L; Pozzi V; Rubini C; Santarelli A; Emanuelli M
    Eur J Clin Invest; 2020 Apr; 50(4):e13220. PubMed ID: 32129473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
    Li J; Yue H; Yu H; Lu X; Xue X
    BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
    Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
    Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.